Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALLOB in rescue interbody fusion
NCT02328287Phase 2Terminated
- Sponsor
- BioSenic
- Start
- Sep 2014
- Primary completion
- Apr 2018
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic osteoblastic cells in post-laminectomy syndrome (PLS), sponsored by BioSenic. Started Sep 2014; status: terminated.
02
Drugs
allogeneic osteoblastic cells
03
Conditions
post-laminectomy syndrome (PLS)
Beyond the preview
Go deeper on NCT02328287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02328287.